# Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/safety-and-activity-of-mirvetuximab-soravtansine-imgn853-a-folate-receptor-alpha/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kathleen N. Moore,Lainie P. Martin,David M. O’Malley,Ursula A. Matulonis,Jason Konner,Raymond P. Perez,Todd M. Bauer,Rodrigo Ruiz‐Soto,Michael J. Birrer |
| Citations | 222 |
| DOI | 10.1200/jco.2016.69.9538 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/5559878 |
| OpenAlex ID | https://openalex.org/W2567395185 |
| PMID | 28029313 |
| Type | article |
| Year | 2017 |

## Paper authors

- [David M. O’Malley](https://scholariq.org/researchers/david-m-o-malley/)
- [Lainie P. Martin](https://scholariq.org/researchers/lainie-p-martin/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

## Paper topics

- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Intraperitoneal and Appendiceal Malignancies](https://scholariq.org/topics/intraperitoneal-and-appendiceal-malignancies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.